Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Glucagon-like peptide-1 analogs are a new class of drug for treatment of type 2 diabetes. One of their advantages (over insulin?) is that they have a lower risk of causing hypoglycemia. Licenced : exenatide (2005), liraglutide (2010) Under investigation : albiglutide, taspoglutide, AVE0010.